Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uros Markovic

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Clinical Case Reports|September 20, 2019
A rare case of multiple myeloma with intracranial extramedullary relapse: One or more myeloma clones?Uros Markovic, Valeria Calafiore, Enrica Martino, et al.
Haematologica|May 5, 2022
Relapse of immune-mediated thrombotic thrombocytopenic purpura following mRNA COVID-19 vaccination: a prospective cohort studyGaetano Giuffrida, Uros Markovic, Annalisa Condorelli, et al.
Orphanet Journal of Rare Diseases|February 14, 2023
Glucosylsphingosine (Lyso-Gb1) as a reliable biomarker in Gaucher disease: a narrative reviewGaetano Giuffrida, Uros Markovic, Annalisa Condorelli, et al.
Cancers|December 10, 2021
Role of Serum Free Light Chain Assay in Relapsed/Refractory Multiple Myeloma. A Real-Life Unicentric Retrospective StudyUros Markovic, Alessandra Romano, Claudia Bellofiore, et al.
Journal of Clinical Medicine|March 29, 2023
Myelofibrosis and Survival Prognostic Models: A Journey between Past and FutureAndrea Duminuco, Antonella Nardo, Gaetano Giuffrida, et al.
Clinical Case Reports|April 11, 2020
Serum free light chains and multiple myeloma: Is it time to extend their application?Uros Markovic, Valerio Leotta, Daniele Tibullo, et al.
Journal of Clinical Medicine|November 26, 2022
Combination of Interleukin-6, C-Reactive Protein and Procalcitonin Values as Predictive Index of Sepsis in Course of Fever Episode in Adult Haematological Patients: Observational and Statistical StudyDaniela Carcò, Paolo Castorina, Paola Guardo, et al.
Pharmaceuticals (Basel, Switzerland)|August 28, 2025
Old Therapy, New Questions: Rethinking Phlebotomy in a Pharmacologic LandscapeAndrea Duminuco, Patrick Harrington, Vittorio Del Fabro, et al.
Cancers|August 26, 2023
Lenalidomide plus Dexamethasone Combination as First-Line Oral Therapy of Multiple Myeloma Patients: A Unicentric Real-Life StudyVittorio Del Fabro, Mary Ann Di Giorgio, Valerio Leotta, et al.
International Journal of Molecular Sciences|March 13, 2025
No Benefit from Hydroxyurea Pre-Treatment in Frontline Chronic Myeloid Leukemia Therapy and Evidence of Quantitative Changes in the <i>BCR::ABL1</i> Transcript LevelFabio Stagno, Stefania Stella, Salvatore Leotta, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Clinical Case Reports|September 20, 2019
A rare case of multiple myeloma with intracranial extramedullary relapse: One or more myeloma clones?Uros Markovic, Valeria Calafiore, Enrica Martino, et al.
Haematologica|May 5, 2022
Relapse of immune-mediated thrombotic thrombocytopenic purpura following mRNA COVID-19 vaccination: a prospective cohort studyGaetano Giuffrida, Uros Markovic, Annalisa Condorelli, et al.
Orphanet Journal of Rare Diseases|February 14, 2023
Glucosylsphingosine (Lyso-Gb1) as a reliable biomarker in Gaucher disease: a narrative reviewGaetano Giuffrida, Uros Markovic, Annalisa Condorelli, et al.
Cancers|December 10, 2021
Role of Serum Free Light Chain Assay in Relapsed/Refractory Multiple Myeloma. A Real-Life Unicentric Retrospective StudyUros Markovic, Alessandra Romano, Claudia Bellofiore, et al.
Journal of Clinical Medicine|March 29, 2023
Myelofibrosis and Survival Prognostic Models: A Journey between Past and FutureAndrea Duminuco, Antonella Nardo, Gaetano Giuffrida, et al.
Clinical Case Reports|April 11, 2020
Serum free light chains and multiple myeloma: Is it time to extend their application?Uros Markovic, Valerio Leotta, Daniele Tibullo, et al.
Journal of Clinical Medicine|November 26, 2022
Combination of Interleukin-6, C-Reactive Protein and Procalcitonin Values as Predictive Index of Sepsis in Course of Fever Episode in Adult Haematological Patients: Observational and Statistical StudyDaniela Carcò, Paolo Castorina, Paola Guardo, et al.
Pharmaceuticals (Basel, Switzerland)|August 28, 2025
Old Therapy, New Questions: Rethinking Phlebotomy in a Pharmacologic LandscapeAndrea Duminuco, Patrick Harrington, Vittorio Del Fabro, et al.
Cancers|August 26, 2023
Lenalidomide plus Dexamethasone Combination as First-Line Oral Therapy of Multiple Myeloma Patients: A Unicentric Real-Life StudyVittorio Del Fabro, Mary Ann Di Giorgio, Valerio Leotta, et al.
International Journal of Molecular Sciences|March 13, 2025
No Benefit from Hydroxyurea Pre-Treatment in Frontline Chronic Myeloid Leukemia Therapy and Evidence of Quantitative Changes in the <i>BCR::ABL1</i> Transcript LevelFabio Stagno, Stefania Stella, Salvatore Leotta, et al.
Pageof 5